oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A European survey of oncology nurse breakthrough cancer pain practices
Division of Emergencies and Critical Care, Department of Research and Development, Oslo University Hospital Ullevål, Oslo, Norway; Lovisenberg Diaconal University College, Oslo, Norway .
University Medical Centre Groningen, Groningen, Netherlands .
Ag. Anargyri Oncology Hospital, Athens, Greece .
Department of Oncology, Section of Cancer Rehabilitation, Karolinska University Hospital, Stockholm, Sweden .
Show others and affiliations
2013 (English)In: European Journal of Oncology Nursing, ISSN 1462-3889, E-ISSN 1532-2122, Vol. 17, no 1, 95-100 p.Article in journal (Refereed) Published
Abstract [en]

Purpose of the research: Breakthrough cancer pain (BTCP) is a prevalent type of pain in which the nurse can play an important role in improving patients' pain symptoms and overall well-being. Nurses' experience with BTCP (number of patients, and estimates of severity and frequency), the treatment of BTCP (pharmacological and nonpharmacological treatments normally used), ratings of the importance of treatment factors, and reasons given for not advising patients to take strong painkillers are presented in the present paper.

Methods and sample: Nurses from 12 European countries, who cared for patients with cancer, took part in a survey. In total 1618 nurses were recruited and 1241 completed the survey questionnaire.

Key results: Almost 90% of the nurses were female, and 50.4% had >9 years of experience in oncology nursing. The majority of the nurses (47%) said that a patient typically suffered from BTCP 2-3 times a day, and the severity of the pain for the patients was described as severe by 75.5%. In all, 38.4% of the nurses were unaware that medications specifically intended for treatment of BTCP exist, and 57% reported that oral opioids were normally prescribed for BTCP at their workplace. While 38% said they did not use nonpharmacological treatments for BTCP, the most common treatment approach was positional change (used by 76.6%). The treatment varied between the European countries.

Conclusion: Patients do not receive the appropriate medical treatment for their BTCP. Nurses need better training about BTCP in general, and BTCP assessment and management specifically. (C) 2012 Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
2013. Vol. 17, no 1, 95-100 p.
Keyword [en]
breakthrough cancer pain, nurses attitudes, nurses experiences, oncology, survey questionnaire, treatments
National Category
Nursing
Research subject
Nursing Science
Identifiers
URN: urn:nbn:se:oru:diva-36307DOI: 10.1016/j.ejon.2012.05.005ISI: 000314013000014PubMedID: 22742829Scopus ID: 2-s2.0-84871478705OAI: oai:DiVA.org:oru-36307DiVA: diva2:746517
Note

Funding Agency:

Nycomed: A Takeda Company

Available from: 2014-09-12 Created: 2014-09-02 Last updated: 2017-10-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Wengström, Yvonne
In the same journal
European Journal of Oncology Nursing
Nursing

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 23 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf